BIOCHEMICAL AND MOLECULAR-GENETIC ARRAYS OF CHRONIC MYELOID LEUKEMIA: MANAGEMENT AND PROGNOSIS IMPACT

EHA Library, Vasile Musteata, 4209529

DEVELOPMENT AND EVALUATION OF A NOVEL EXOSOME–SULFORAPHANE FORMULATION FOR ANTI-CANCER ACTIVITY IN CHRONIC MYELOID LEUKAEMIA

EHA Library, BANAN ALKHATAYBEH, 4209530

IMPACT OF BASOPHILIA AND EOSINOPHILIA ON IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA

EHA Library, Siham Belkadi, 4209531

RESULTS OF TWO-STEP REDUCED-DOSE TKI THERAPY FOLLOWED BY TREATMENT-FREE OBSERVATION IN CML PATIENTS IN READIT (STUDY OF REDUCTION AND DISCONTINUATION TREATMENT OF TKI) AND POST-STUDY FOLLOW-UP

EHA Library, Ekaterina Chelysheva, 4209532

MANAGEMENT OF CML AND SECOND PRIMARY MALIGNANCIES IN THE ERA OF MODERN THERAPIES: REAL-WORLD STRATEGIES AND IMPACT ON CLINICAL OUTCOMES.

EHA Library, Gianni Binotto, 4209533

TKI DOSE INTENSITY AND TREATMENT DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A SINGLE CENTER ANALYSIS

EHA Library, Daniele Sannipoli, 4209534

NINE-YEARS FOLLOW-UP OF THE PHASE I/II TRIAL OF IMATINIB DISCONTINUATION AFTER PIOGLITAZONE (EDI-PIO) IN CHRONIC MYELOID LEUKEMIA PATIENTS IN DEEP MOLECULAR RESPONSE

EHA Library, Katia Pagnano, 4209535

ULTRA-EARLY MOLECULAR RESPONSE AT 6 WEEKS OF ASCIMINIB THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Bingbing Wen, 4209536

PREDICTORS OF OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE IN THE MODERN ERA

EHA Library, Nicholas Short, 4209537

PROSPECTIVE VALIDATION AND CLINICAL FOLLOW-UP OF DIGITAL PCR FOR BCR::ABL1 QUANTIFICATION IN CHRONIC MYELOID LEUKAEMIA IN CHRONIC PHASE (CML-CP)

EHA Library, Trung Ngo, 4209538

LONG-TERM OUTCOMES OF PONATINIB TREATMENT IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA WITH OR WITHOUT THE T315 MUTATION

EHA Library, Elza Lomaia, 4209540

XS003 ELIMINATES NILOTINIB FOOD INTERACTIONS ENABLING OPTIMIZED DOSE REDUCTIONS, RESULTING IN MITIGATED QT-PROLONGATION RISK

EHA Library, Leif Stenke, 4209541

REAL-WORLD ANALYSIS OF FIRST-LINE TKI USE IN CML-CP: A 16-YEAR MULTICENTER EXPERIENCE

EHA Library, Jian Huang, 4209542

VERY LONG-TERM RESULTS OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOLLOWED BY TYROSINE KINASE INHIBITORS (TKI) FOR CP-CML

EHA Library, Mauricette Michallet, 4209543

INCIDENCE OF THE DEVELOPMENT OF PROTEINURIA FOLLOWING DASATINIB THERAPY IN CML PATIENTS AND ITS ASSOCIATION WITH THE OCCURRENCE OF PLEURAL EFFUSION

EHA Library, Eleanore Musick, 4209544

ELN RECOMMENDED RESPONSE MILESTONES PREDICT SURVIVAL AND DEEP MOLECULAR RESPONSE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING SECOND-GENERATION TYROSINE KINASE INHIBITOR

EHA Library, Guorong Chai, 4209545

IMPACT OF BETA‑THALASSEMIA TRAIT ON RISK STRATIFICATION AND OUTCOMES IN CHRONIC MYELOID LEUKEMIA.

EHA Library, Aytan Shirinova, 4209546

NONLINEAR ASSOCIATION BETWEEN PRE-DISCONTINUATION DOSE INTENSITY AND TREATMENT-FREE REMISSION OUTCOMES IN CHRONIC MYELOID LEUKEMIA: A REAL-WORLD ANALYSIS

EHA Library, Dae-Ho Choi, 4209547

CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND SOLID ORGAN TRANSPLANT: A 15-PATIENT CASE SERIES

EHA Library, Mohammed Al Kurnas, 4209548

EFFICACY AND SAFETY OF DIFFERENT NILOTINIB DOSES AS SECOND-LINE THERAPY IN PATIENTS WITH CML RECEIVED FIRST-LINE IMATINIB: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Hongju Yan, 4209549

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS UNDER 18 YEARS OF AGE WITH CHRONIC MYELOID LEUKEMIA; LONG-TERM OUTCOMES

EHA Library, Malek Benakli, 4209550

FRONTLINE TREATMENT APPROACHES AND THEIR IMPACT ON THE OUTCOMES OF PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKAEMIA WITH HYPERLEUKOCYTOSIS: A SINGLE CENTRE CHART REVIEW IN THE UNITED KINGDOM

EHA Library, Adrian Choy, 4209551

IMPLEMENTATION OF A THERAPEUTIC DRUG MONITORING PROGRAM FOR IMATINIB DOSAGE INDIVIDUALIZATION IN PATIENTS WITH CML AND GIST: A PILOT STUDY.

EHA Library, Monica Alejandra Romero Riquelme, 4209552

ANALYSIS OF THE IMPACT OF TYROSINE KINASE INHIBITORS ON RENAL FUNCTION IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Yunfan Yang, 4209553

REAL-WORLD ASSESSMENT OF SYMPTOM BURDEN USING ESAS SCORE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH ASCIMINIB

EHA Library, Ana Flavia Patiño, 4209554

REAL-WORLD OUTCOMES OF ASCIMINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA RESISTANT OR INTOLERANT TO AT LEAST TWO TYROSINE KINASE INHIBITORS: A SINGLE-CENTER RETROSPECTIVE STUDY IN POLAND

EHA Library, Joanna Wącław-Koziara, 4209555

PRELIMINARY GLOBAL TRENDS CAPTURED THROUGH A DIGITAL QUALITY OF LIFE (QOL) TRACKER TOOL THAT HAVE AN IMPACT ON DAILY LIFE IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML)

EHA Library, Susanne Saussele, 4209556

TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKAEMIA: A SURVEY OF PRACTICE OF HEALTHCARE PROFESSIONALS IN THE UNITED KINGDOM

EHA Library, NIA EVANS, 4209557

REAL-WORLD PEDIATRIC CML IN A LOWER-MIDDLE-INCOME COUNTRY: LONG-TERM SURVIVAL, DEEP MOLECULAR RESPONSE, GROWTH IMPAIRMENT, AND QUALITY-OF-LIFE OUTCOMES OVER A DECADE

EHA Library, Syed Yasar, 4209558

REAL-WORLD EFFECTIVENESS AND SAFETY OF OLVEREMBATINIB IN CHRONIC MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Yunfan Yang, 4209559

PRE-TREATMENT COMORBIDITIES AND MANAGEMENT OF TYROSINE KINASE INHIBITOR THERAPY IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Tugcan Alp Kirkizlar, 4209560

TIMING TO MAJOR MOLECULAR RESPONSE (MMR) DOES NOT IMPACT OVERALL SURVIVAL IN CHRONIC PHASE CML: A MULTICENTRE REAL-WORLD PERUVIAN STUDY

EHA Library, Naty López Córdova, 4209561

GENERIC VERSUS BRANDED IMATINIB IN CHRONIC MYELOID LEUKEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 21 OBSERVATIONAL STUDIES

EHA Library, Shankar Biswas, 4209562

EVALUATION OF THE EFFICACY OF IMATINIB IN NEWLY DIAGNOSED CML PATIENTS WITH T(9;22;?)(Q34;Q11.2;?) THREE-WAY TRANSLOCATION

EHA Library, WUSHENG WANG, 4209563

ANALYSIS OF SECONDARY MALIGNANCIES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH TYROSINE KINASE INHIBITORS – A SINGLE-CENTER EXPERIENCE FROM POLAND

EHA Library, Monika M. Biernat, 4209564

SINGLE-TUBE MULTIPLEX ABSOLUTE QUANTIFICATION OF BCR::ABL1 TRANSCRIPTS FOR SENSITIVE MRD MONITORING IN CHRONIC MYELOID LEUKEMIA

EHA Library, Dries Van Hemelen, 4209565

RAPID MOLECULAR RESPONSES AND PRESERVED QUALITY OF LIFE WITH ASCIMINIB IN CHRONIC MYELOID LEUKEMIA: A REAL-WORLD STUDY

EHA Library, bingyu lin, 4209566

TOWARDS INDIVIDUALIZED TREATMENT STEWARDSHIP IN CHRONIC MYELOID LEUKEMIA BASED ON COMBINATION OF MOLECULAR DATA AND MATHEMATICAL MODELING

EHA Library, Ingo Roeder, 4209567

PAX5::MLLT3 FUSION DEFINES A HIGH-RISK SHIFT TOWARD LYMPHOID BLAST EVOLUTION IN CML

EHA Library, Matteo Caridi, 4209568

DIFFERENT BCR::ABL1 TRANSCRIPT LEVELS @ 3 AND 6 MONTHS MIGHT BE USEFUL IN IDENTIFYING WARNING/RESISTANT CML PATIENTS WHEN USING 2G-TKIS AS FRONTLINE TREATMENT

EHA Library, Fabio Stagno, 4209569

LONG-TERM OUTCOMES OF CHRONIC MYELOID LEUKEMIA  IN CHILDREN AND ADOLESCENTS TREATED WITH GENERIC IMATINIB AS FIRST-LINE AND ITK2 AS SECOND-LINE THERAPY : A RETROSPECTIVE STUDY.

EHA Library, Nabila Rekab, 4209570

A PHASE 3 STUDY OF OLVEREMBATINIB (HQP1351) IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA: POLARIS-2 TRIAL IN PROGRESS

EHA Library, Elias Jabbour, 4209571

ASC4KIDS-2 TRIAL-IN-PROGRESS: ASCIMINIB IN PEDIATRIC CHRONIC MYELOID LEUKEMIA WITH OR WITHOUT T315I

EHA Library, Markus Metzler, 4209572

REAL-WORLD EXPERIENCE OF TREATMENT-FREE REMISSION AFTER TKI DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: WITH REDUCED FREQUENCY OF MOLECULAR MONITORING OF BCR::ABL1 QPCR TEST

EHA Library, Maria Agustina Perusini, 4209574

STAMP INHIBITORS IMPROVE EARLY MOLECULAR RESPONSE (BCR::ABL1 <5% AT 3 MONTHS) IN CHRONIC-PHASE CML: A MULTICENTER REAL-WORLD COHORT FROM SOUTHERN CHINA

EHA Library, Lisi Huang, 4209575

COMPARISON OF THE INCIDENCE OF CARDIOVASCULAR ADVERSE EVENTS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA RECEIVING TYROSINE KINASE INHIBITORS WITH REPRESENTATIVES OF THE GENERAL POPULATION

EHA Library, Nadezhda Shnalieva, 4209576

CHRONIC MYELOID LEUKAEMIA IN THE PAEDIATRIC AND YOUNG ADULT POPULATION – A MULTI-CENTRE RETROSPECTIVE STUDY

EHA Library, Abbie Wilson, 4209577

REAL WORLD MOLECULAR RESPONSE TO INHIBITOR ALLOSTERIC IN ADULT CHRONIC MYELOID LEUKEMIA: A MEXICAN MULTICENTER RETROSPECTIVE COHORT

EHA Library, Álvaro Cabrera García, 4209578

CURRENT STATUS SURVEY OF TOLERABILITY BURDEN OF FIRST- OR SECOND-LINE TKI THERAPY IN CHINESE PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)

EHA Library, Weiming Li, 4209579

MOLECULAR AND CLINICAL OUTCOMES OF FIRST-LINE TKIS IN A MULTIETHNIC CML COHORT UNDER UNIVERSAL ACCESS IN MALAYSIA: INTERIM ANALYSIS OF THE MYMPN RWE STUDY

EHA Library, Lee Ping Chew, 4209580

ASCIMINIB IN CHRONIC-PHASE CML AFTER PRIOR TKI INTOLERANCE OR RESISTANCE: REAL-WORLD OUTCOMES FROM A SINGLE-CENTER COHORT

EHA Library, Aikaterini Kolotsiou, 4209581

ADOLESCENT AND YOUNG ADULT CHRONIC MYELOID LEUKEMIA IN MALAYSIA: 25-YEAR EPIDEMIOLOGICAL PROFILE AND TREATMENT OUTCOMES FROM A MALAYSIAN SINGLE-CENTRE ANALYSIS

EHA Library, Syazwani Jamhuri, 4209582

REAL-WORLD PERFORMANCE OF ELTS AND SOKAL FOR PREDICTION OF EARLY MOLECULAR RESPONSE IN CHRONIC-PHASE CML TREATED WITH MIXED FRONTLINE TKIS

EHA Library, Diana Grasu, 4209583

THERAPEUTIC RESULTS OF SECOND-GENERATION TKI FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA

EHA Library, Yousra Fakhfakh Derbel, 4209584

ONE VS. 2 VS. ≥3 TET2 MUTATIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA: CO-MUTATION PATTERNS AND PROGNOSTIC CORRELATES

EHA Library, Yousuf Muhammad, 4209585

EXPERIENCE WITH PONATINIB IN CHRONIC MYELOID LEUKAEMIA IN PARAGUAY

EHA Library, José Zarza, 4209586

TRIAL IN PROGRESS: REAL-WORLD STUDY OF ASCIMINIB IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA IN CHINA (ASC4CN)

EHA Library, Weiming Li, 4209587

FLUMATINIB IN CHRONIC MYELOID LEUKEMIA WITH RARE BCR-ABL TRANSCRIPTS: A REPORT OF 4 CASES AND ANALYSIS OF EFFICACY CHARACTERISTICS

EHA Library, Qiguo Zhang, 4209588

REAL-WORLD CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN PEDIATRIC CHRONIC MYELOID LEUKEMIA: A MEXICAN COHORT STUDY

EHA Library, Emmanuel Rolando Rodríguez Cedeño, 4209589

ADDITIONAL CHROMOSOMAL ABNORMALITIES AT DIAGNOSIS PREDICT INFERIOR EARLY MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA: A SINGLE-CENTER  STUDY

EHA Library, Sanjukta S Rao, 4209590

ASCIMINIB IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A REAL-WORLD ANALYSIS OF EFFICACY AND SAFETY

EHA Library, Xinrui Zhang, 4209591

COMPARATIVE REVIEW OF EMERGING TYROSINE KINASE INHIBITORS IN THE PIPELINE FOR CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

EHA Library, Mohammad Riyaz Beg, 4209592

IMPACT OF ADDITIONAL CYTOGENETIC ABNORMALITIES ON THE EVOLUTION OF CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE STUDY FROM NORTHERN MOROCCO.

EHA Library, Tarik Arahou, 4209593

MYELOID BLAST TRANSFORMATION OF CHRONIC MYELOID LEUKEMIA INTO ACUTE MYELOID LEUKEMIA: TWO DISTINCT EVOLUTIONARY PATHWAYS IN THE TKI ERA

EHA Library, daami mayssa, 4209594

A STUDY ON PREGNANCY SUCCESS, BIRTHS, AND MISCARRIAGES IN CML-CP PATIENTS DURING TYROSINE KINASE INHIBITOR THERAPY: A SINGLE-CENTER ANALYSIS.

EHA Library, Eriko Sato, 4209595

REAL-WORLD OUTCOMES OF FRONTLINE IMATINIB IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE MONOCENTRIC SURVIVAL ANALYSIS

EHA Library, Imane Chajai, 4209596

CLONAL HYPEREOSINOPHILIA IN A 20-YEAR-OLD MALE PRESENTING WITH NEUROPATHY AND VISUAL DISTURBANCE: CASE REPORT

EHA Library, Jan Francis Alpay, 4209597

DIFFUSE LARGE B-CELL LYMPHOMA DURING DEEP MOLECULAR RESPONSE IN CML: BLAST CRISIS OR SECOND MALIGNANCY?

EHA Library, wafa chenbah, 4209598

EXTRAMEDULLARY T-LYMPHOBLASTIC TRANSFORMATION DURING CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE

EHA Library, Ameni Yahia, 4209599

CHRONIC MYELOID LEUKEMIA DEVELOPING AFTER BREAST CANCER REMISSION

EHA Library, Tsira Gogokhia, 4209600

INVESTIGATION OF THE REGULATORY MECHANISM BY WHICH THE HMGA1/RACK1 AXIS MEDIATES STAT3 ABERRATION TO DRIVE MALIGNANT CLONES IN MDS

EHA Library, lijuan Li, 4209601

REFINING GERMLINE TESTING IN MYELOID NEOPLASMS: CLINICAL VARIABLES IMPROVE DIAGNOSTIC YIELD IN A REAL-WORLD COHORT

EHA Library, Guillermo Ramil, 4209602

CLINICAL AND MOLECULAR FEATURES OF CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE (CCUS): IMPACT OF THERAPY-RELATED CASES IN A SINGLE-CENTER COHORT.

EHA Library, Clara Nadal Pellise, 4209603

CRISPRI SCREENING IDENTIFIES CANDIDATE MONOSOMY 7-ASSOCIATED GENES CONTRIBUTING TO MALIGNANT TRANSFORMATION IN GATA2 DEFICIENCY

EHA Library, Maria Magallon-Mosella, 4209604

THE MECHANISM OF LOW-DOSE DESLANOSIDE IN ENHANCING THE THERAPEUTIC EFFICACY OF AZACITIDINE IN MYELODYSPLASTIC SYNDROMES

EHA Library, Jiarun Li, 4209606

HEMATOPOIETIC PROGENITOR HETEROGENEITY ACROSS RISK CATEGORIES IN MYELODYSPLASTIC SYNDROMES

EHA Library, Christina Kalpadaki, 4209607

EPIGENETICS OF VEXAS AND MDS REVEALS AGE-DEPENDENT SIGNALS AND INVARIANT LONGITUDINAL METHYLATION PATTERNS AFTER HYPOMETHYLATING AGENTS THERAPY

EHA Library, Francesca Romano, 4209608

STRATIFICATION OF PATIENTS PER TP53 CLONAL BURDEN REFINES PROGNOSIS BEYOND SINGLE- AND MULTI-HIT ALLELIC STATE IN MYELOID NEOPLASMS

EHA Library, Oriol Calvete, 4209609

CROSS-COHORT SINGLE-CELL TRANSCRIPTOMIC INTEGRATION REVEALS SUBTYPE-ASSOCIATED TRANSCRIPTIONAL REMODELING IN MYELODYSPLASTIC SYNDROMES

EHA Library, Yan Liu, 4209610

SINGLE-CELL FULL-LENGTH TP53 CDNA SEQUENCING TO RESOLVE CLONAL AND ALLELIC DISTRIBUTION IN HEMATOLOGIC MALIGNANCIES

EHA Library, Emili Cid, 4209611

CORRELATION BETWEEN FLOW CYTOMETRY ERYTHROID MARKERS (CD71 AND CD36) AND CYTOMORPHOLOGICAL ASSESSMENT OF ERYTHROBLAST DYSPLASIA IN BONE MARROW

EHA Library, Alicja Dudzik, 4209612

S100A12 DRIVES MACROPHAGE DIFFERENTIATION DEFECT AND ER STRESS CROSSTALK IN MYELODYSPLASTIC SYNDROMES: MOLECULAR MECHANISMS AND THERAPEUTIC EXPLORATION

EHA Library, Liansheng Zhang, 4209613

BONE MARROW STROMAL MODULATION IN MYELODYSPLASTIC SYNDROMES

EHA Library, Matilde Boada Burutaran, 4209614

SELF-REPORTED FATIGUE IN PATIENTS WITH MYELODYSPLASTIC NEOPLASMS IS LINKED TO INNATE IMMUNE AND MITOCHONDRIAL DYSFUNCTION

EHA Library, Verena Petzer, 4209615

MOLECULAR ARCHITECTURE OF TP53-MUTATED MYELOID NEOPLASMS IN A SINGLE-CENTER COHORT: CO-MUTATION PATTERNS, MULTI-HIT STATUS, AND CYTOGENOMIC PROFILING

EHA Library, Lucía Gómez-Pérez, 4209616

RNA PSEUDOURIDYLATION-DRIVEN TRANSLATION AND GENOME REGULATION IN HEMATOPOIETIC STEM CELLS AND MYELODYSPLASTIC SYNDROMES

EHA Library, Gaia Menichincheri, 4209617

FAMILIAL CHARACTERIZATION AND VARIANT INTERPRETATION OF A GERMLINE VARIANT IN DDX41 IN THE CONTEXT OF MYELOID NEOPLASM PREDISPOSITION

EHA Library, Ada Esteban-Figuerola, 4209618

CLINICAL AND MOLECULAR HETEROGENEITY OF SF3B1-MUTATED MYELODYSPLASTIC SYNDROMES:IMPACT OF VARIANT ALLELE FREQUENCY, MUTATION SITES, AND CO-MUTATION PATTERNS

EHA Library, Kainan Zhang, 4209619

ISOLATED PPM1D MUTATIONS IN BONE MARROW: CLINICOPATHOLOGIC FEATURES IN A 52-PATIENT COHORT

EHA Library, April Chiu, 4209620

THE EFFECTS OF BLOOD SERA FROM PATIENTS WITH MDS WITH DIFFERENT KARYOTYPES ON THE GROWTH OF MULTIPOTENT MESENCHYMAL STROMAL CELLS FROM HEALTHY DONORS

EHA Library, Nataliya Petinati, 4209621

THERMODYNAMIC CHARACTERISATION OF DDX41 MISSENSE VARIANTS OF UNCERTAIN SIGNIFICANCE

EHA Library, Natsuki Omori Rison, 4209622

RED BLOOD CELL PHENOTYPES IN LOWER RISK MYELODYSPLASTIC SYNDROMES : ASSOCIATION WITH DISEASE RISK

EHA Library, Pinelopi Vryttia, 4209623

ESTABLISHING A VITAMIN B5–COENZYME A METABOLIC SCORE TO CHARACTERIZE HEME BIOSYNTHESIS AND ENABLE CLINICAL MONITORING IN SF3B1-MUTATED MYELODYSPLASTIC NEOPLASMS.

EHA Library, Shoshana Burke, 4209624

PERIPHERAL BLOOD NK CELLS AND LMR: INDEPENDENT IMMUNE PROGNOSTIC BIOMARKERS IN NEWLY DIAGNOSED MDS

EHA Library, Xiangli Chen, 4209625

INTERNATIONAL MULTICENTER EXTERNAL VALIDATION OF THE JAKPOT PREDICTION RULE TO GUIDE JAK2 MUTATION TESTING IN PATIENTS WITH ERYTHROCYTOSIS

EHA Library, Benjamin Chin-Yee, 4209626

A PROGNOSTIC NOMOGRAM FOR SURVIVAL STRATIFICATION IN MYELODYSPLASTIC NEOPLASMS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Kaili Min, 4209627

EFFICACY AND SAFETY OF TISLELIZUMAB COMBINED WITH AZACITIDINE AND VENETOCLAX IN MYELODYSPLASTIC NEOPLASMS WITH INCREASED BLASTS (MDS-IB): A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Zi-Yuan Nie, 4209628

A PRECISE DIFFERENTIAL DIAGNOSTIC MODEL CONSTRUCTED BASED ON COMPARATIVE ANALYSIS OF CLINICAL CHARACTERISTICS BETWEEN APLASTIC ANEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS

EHA Library, Rong Fu, 4209629

CHARACTERISTICS OF PATIENTS WITH MDS AND MARROW FIBROSIS: SINGLE INSTITUTION EXPERIENCE

EHA Library, Ahmed Shaban, 4209630

EFFICACY AND SAFETY OF LISAFTOCLAX COMBINED WITH AZACITIDINE IN TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROME: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Jihao Zhou, 4209631